In-Use Safety Evaluation to Determine the Dermal Irritation Potential and Consumer Perception of a Test Material - In-Use Safety Evaluation to Determine the Dermal Irritation Potential and Consumer Perception of a Test Material

ION CORPORATIO0 个研究点目标入组 35 人开始时间: 2022年6月7日最近更新: 2024年9月2日

适应症

试验速览

暂无简介。

•a) Female subject (if applicable) is pregnant, nursing, planning a pregnancy, or not using adequate birth control; b) Subject has received treatment with sympathomimetics, antihistamines, vasoconstrictors, non-steroidal anti-inflammatory agents, and/or systemic or topical corticosteroids within one week prior to initiation of the study; c) Subject has a history of acute or chronic dermatologic, medical, and/or physical conditions which would preclude application of the test material and/or could influence the outcome of the study; d) Subject is currently taking certain medications which, in the opinion of the Principal Investigator, may interfere with the study; e) Subject has known allergies to skin treatment products or cosmetics, toiletries, and/or topical drugs; f) Subject has a history of skin cancer, or is currently undergoing treatment for active cancer of any kind; g) Subject has insulin-dependent diabetes.

发起方

ION CORPORATIO